Skip to content

Levetiracetam

Generic Medicine With 64 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Levetiracetam

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Seizures Levetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. ... Read moreLevetiracetam is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Dosage And Administration

Adults and adolescents from 16 years of age: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks. The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response. The maximum dose is 1500 mg twice daily.Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.Pediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used. Monotherapy: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established. Add-on therapy: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults. Add-on therapy: For infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.

Side Effects

Most common adverse reactions (incidence ≥ 5% more than placebo) include: Adult patients: somnolence, asthenia, infection and dizziness Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability

Precautions And Warnings

Renal impairment: The administration of levetiracetam to patients with renal impairment may require dose adjustment. In patients with severely impaired hepatic function, assessment of renal function is recommended before dose selection.Acute kidney injury: The use of levetiracetam has been very rarely associated with acute kidney injury with a time to onset ranging from a few days to several months.Blood cell counts: Rare cases of decreased blood cell counts (neutropenia, agranulocytosis, leucopenia, thrombocytopenia and pancytopenia) have been described in association with levetiracetam administration, generally at the beginning of the treatment. Complete blood cell counts are advised in patients experiencing important weakness, pyrexia, recurrent infections or coagulation disorders.Suicide: Suicide, suicide attempt, suicidal ideation and behaviour have been reported in patients treated with anti-epileptic agents (including levetiracetam). A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour. The mechanism of this risk is not known. Therefore patients should be monitored for signs of depression and/or suicidal ideation and behaviours and appropriate treatment should be considered. Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/or suicidal ideation or behaviour emerge.Paediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Available data in children did not suggest an impact on growth and puberty. However, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.

Pregnancy And Lactation

Levetiracetam is not recommended during pregnancy and in women of childbearing potential not using contraception unless clinically necessary. Levetiracetam is excreted in human breast milk. Therefore, breastfeeding is not recommended. However, if levetiracetam treatment is needed during breastfeeding, the benefit/risk of the treatment should be weighed considering the importance of breastfeeding. No impact on fertility was detected in animal studies. No clinical data are available, the potential risk for humans is unknown.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 64

Sorted By
Tablet

Citazar 250 mg

Generic: Levetiracetam

15.11Taka / Unit

View Medicine
Tablet

Citazar 500 mg

Generic: Levetiracetam

25.17Taka / Unit

View Medicine
Tablet

Citazar 250 mg

Generic: Levetiracetam

15.11Taka / Unit

View Medicine
Tablet (Extended Release)

Citazar XR 750 mg

Generic: Levetiracetam

35.00Taka / Unit

View Medicine
Tablet (Extended Release)

Citazar XR 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Oral Solution

Eletam 500 mg/5 ml

Generic: Levetiracetam

400.00Taka / 100 ml

View Medicine
Tablet

Eletam 250 mg

Generic: Levetiracetam

16.00Taka / Unit

View Medicine
Tablet

Eletam 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Tablet

Epicet 250 mg

Generic: Levetiracetam

16.00Taka / Unit

View Medicine
Tablet

Epicet 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Oral Solution

Epicet 500 mg/5 ml

Generic: Levetiracetam

400.00Taka / 100 ml

View Medicine
IV Infusion

Epicet 500 mg/5 ml

Generic: Levetiracetam

40.00Taka / 5 ml ampoule

View Medicine
Tablet (Extended Release)

Epicet XR 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Tablet (Extended Release)

Epicet XR 750 mg

Generic: Levetiracetam

35.00Taka / Unit

View Medicine
Tablet (Extended Release)

Epicet XR 1000 mg

Generic: Levetiracetam

45.00Taka / Unit

View Medicine
Tablet

Erata 500 mg

Generic: Levetiracetam

30.30Taka / Unit

View Medicine
Tablet

Erata 250 mg

Generic: Levetiracetam

16.25Taka / Unit

View Medicine
Tablet

Iracet 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
IV Infusion

Iracet 500 mg/5 ml

Generic: Levetiracetam

40.13Taka / 5 ml ampoule

View Medicine
Oral Solution

Iracet 500 mg/5 ml

Generic: Levetiracetam

200.61Taka / 50 ml

View Medicine
Tablet

Iracet 250 mg

Generic: Levetiracetam

16.00Taka / Unit

View Medicine
Tablet (Extended Release)

Iracet XR 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Tablet

Lepsytam 500 mg

Generic: Levetiracetam

30.00Taka / Unit

View Medicine
Tablet

Lepsytam 250 mg

Generic: Levetiracetam

16.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250